WINDTREE THERAPEUTICS INC (42) | Business Finance (28)

Browse by Subcategory

Recent Contracts

Form of Warrant Agency Agreement (Filed With SEC on March 24, 2021)
Underwriting Agreement, dated March 23, 2021, by and among the Company and Oppenheimer & Co. Inc., as representative for the several underwriters named therein (Filed With SEC on March 24, 2021)
Project Financing Agreement, dated August 12, 2020, by and between Windtree and Lees Pharmaceutical (HK) Ltd (Filed With SEC on November 16, 2020)
Loan Agreement dated March 17, 2020, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd (Filed With SEC on May 6, 2020)
Binding Term Sheet dated March 18, 2020, between Windtree and Lees Pharmaceutical (HK) LTD (Filed With SEC on May 6, 2020)
Note dated April 20, 2020, between Windtree Therapeutics, Inc. and Newtek Small Business Finance, LLC (Filed With SEC on April 24, 2020)
Amendment to No. 1 dated February 20, 2020 to the Securities Purchase Agreement dated December 6, 2019 by and among Windtree and the purchasers party thereto (Filed With SEC on April 3, 2020)
Form of Registration Rights Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto (Filed With SEC on December 9, 2019)
Form of Warrant (Filed With SEC on March 24, 2021)
Form of Warrant Agency Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 22, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to the Registration Statement on Form S-1, filed on January 27, 2020, as amended (Filed With SEC on May 22, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 19, 2020)
Form of Underwriting Agreement (Filed With SEC on May 19, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 14, 2020)
Form of Warrant Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 6, 2020)
Form of Series I Warrant Amendment dated May 6, 2020 to the Series I Warrant dated December 6, 2019 (Filed With SEC on May 6, 2020)
Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 6, 2020)
Form of Underwriting Agreement (Filed With SEC on May 6, 2020)
Form of Series F Warrant Amendment dated April 24, 2020 (Filed With SEC on April 29, 2020)
Form of Securities Purchase Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto (Filed With SEC on December 9, 2019)
Form of Series I Warrant (Filed With SEC on December 9, 2019)
Loan Agreement (Filed With SEC on October 28, 2019)
Loan Agreement dated October 25, 2018, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd (Filed With SEC on April 16, 2019)
Shareholder Loan Agreement dated November 16, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Shareholder Loan Agreement dated October 26, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Shareholder Loan Agreement dated September 20, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Shareholder Loan Agreement dated April 24, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
Form of Series E Warrant dated December 11, 2018 (Filed With SEC on April 16, 2019)